Navigation Links
New clinical trial to determine ovarian cancer risks in African-American women
Date:2/1/2011

University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting an important new study addressing the lack of knowledge about causes and risk factors for ovarian cancer in African American women. The five-year study is funded by the National Cancer Institute through Case Western Reserve University School of Medicine.

Ovarian cancer, though relatively rare, is the most lethal of all gynecologic cancers. It is the fifth most common cause of cancer death among women behind lung, breast, colorectal and pancreas. African American women have lower incidence rates than women of other races yet have a poorer survival rate.

"This study hopes to address the lack of knowledge about causes of ovarian cancer among African-American women by establishing a multi-site, national collaboration that will educate, treat, and assess both environmental and genetic risk factors in African American women," said Jill S. Barnholtz-Sloan, PhD, the study's principal investigator at UH Case Medical Center and Assistant Professor, Case Western Reserve University School of Medicine. "Ovarian cancer is a deadly disease and it is important that we better understand what causes this disease if we have any hope of preventing it in the future."

The nine-state collaborative study aims to enroll 1,000 African American women between the ages of 20-79 with primary ovarian cancer and an equal amount of same-aged, healthy African American women. Researchers hope to discover how risk factors for ovarian caner in African American women are similar or different from the established risk factors in white women and if the differences can account for racial differences in ovarian cancer incidence (i.e. proportion of newly diagnosed ovarian cancer cases).

"This study will not only help us determine differences in risk factors between African American women and white women but we also anticipate that this study will provide a foundation to conduct studies of other cancers in African American women in the future." said Steven Waggoner, MD, co-primary investigator on the study, Chief of Gynecologic Oncology at UH Case Medical Center and Associate Professor at Case Western Reserve University School of Medicine. "Furthermore it is important for us to determine what factors are associated with poorer survival rates in African American women."


'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
216-844-5158
University Hospitals Case Medical Center
Source:Eurekalert

Related medicine news :

1. Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
2. Most Guidelines for Infectious Diseases Dont Come From Clinical Trial Findings
3. Quality of life measures in breast cancer clinical trials
4. Quality of Life Key Measure in Breast Cancer Clinical Trials
5. Clinical waste management needs specialized regulation
6. VCU findings may help explain some major clinical symptoms of preeclampsia
7. Clinical practitioners not adhering to evidence-based guidelines for osteoarthritis
8. Clinical decision support systems help control inappropriate medical imaging, study suggests
9. Peptide delivers 1-2 punch to breast cancer in pre-clinical study
10. Collaboration offers NIH Clinical Center resources to Damon Runyon clinical investigators
11. Use the right metaphor to get patients to enroll in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
Breaking Medicine Technology: